BARD Peripheral Vascular, Inc., a subsidiary of C. R. Bard, Inc., is a leading player in the medical device industry, specialising in innovative solutions for vascular access and peripheral vascular interventions. Headquartered in the United States, the company operates extensively across North America and Europe, providing critical products that enhance patient care. Founded in the early 1960s, BARD Peripheral Vascular has achieved significant milestones, including the development of advanced catheter technologies and vascular grafts. Their core offerings, such as the innovative AngioJet® Thrombectomy System and various stent systems, are distinguished by their efficacy and reliability in treating vascular diseases. With a strong market position, BARD Peripheral Vascular is recognised for its commitment to quality and innovation, making it a trusted name among healthcare professionals and patients alike.
We don't have data for BARD Peripheral Vascular, Inc., but we can show you information about their parent organization instead.
View parent company